hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06261294 id: CPIP-LUN-A001 briefTitle: OncoSweep Cancer Spotlight and Spectrum Product Line overallStatus: RECRUITING date: 2023-05-23 date: 2025-03-20 date: 2026-03-20 date: 2024-02-15 date: 2024-02-15 name: Pharus Taiwan, Inc. class: INDUSTRY briefSummary: CONQUER cancer study: To collect blood samples from cancer and non-cancer participants for development and validation of the 'OncoSweep Cancer Spotlight and Spectrum Product Line' conditions: Lung Cancer studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 800 type: ESTIMATED name: OncoSweep Lung Spotligh measure: To differentiate lung cancer signals from non-cancer signals based on analysis of OncoSweep Lung Spotlight. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Mackay Memorial Hospital status: RECRUITING city: Taipei state: Zhongshan Dist zip: 104217 country: Taiwan name: Sheng-Hsiung Yang role: CONTACT phone: +886 2 2543-3535 email: lazatemax@gmail.com lat: 25.04776 lon: 121.53185 hasResults: False
nctId: NCT06261281 id: TBI cancel briefTitle: Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patient acronym: IOE-TBI overallStatus: WITHDRAWN date: 2024-02-10 date: 2024-07-10 date: 2024-07-10 date: 2024-02-15 date: 2024-03-06 name: Zeng Changhao class: OTHER briefSummary: This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding or the control group with Nasogastric tube feeding for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared. conditions: Traumatic Brain Injury studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 0 type: ACTUAL name: Rehabilitation therapy name: Intermittent Oro-esophageal Tube Feeding name: Nasogastric tube feeding measure: Concentration of hemoglobin measure: Concentration of albumin measure: Concentration of prealbumin measure: Nutritional status-body mass index measure: Decannulation of tracheostomy tube-placement duration measure: Decannulation of tracheostomy tube-Successful removal measure: Level of consciousness measure: Feeding Amount sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Zheng Da yi Yuan Hospital city: Zhengzhou state: Henan zip: 450000 country: China lat: 34.75778 lon: 113.64861 hasResults: False
nctId: NCT06261268 id: Strip vs FGG briefTitle: Strip Graft w/ Xenogeneic Matrix vs Free Gingival Graft for the Augmentation of Peri-implant Keratinized Mucosa overallStatus: RECRUITING date: 2024-01-29 date: 2024-12-15 date: 2025-07-15 date: 2024-02-15 date: 2024-02-15 name: Universidad Complutense de Madrid class: OTHER briefSummary: The primary objective of this study is to compare changes in peri-implant keratinized mucosa (PIKM) following the application of apically repositioned flap (ARF) using a combination of a Strip graft and a Xenogeneic matrix, or with a free gingival graft (FGG), in implants in the second stage with \<2 mm of PIKM.
Additionally, as a secondary objective, the investigators compare postoperative blood supply in both recipient and donor sites based on the type of graft obtained. Meanwhile, the investigators evaluate differences between the two groups concerning microcirculation values (perfusion units, PU), soft tissue thickness (STT), volume change, vestibular depth, as well as clinical, aesthetic, and patient-reported outcome measures (PROMS). conditions: Peri-Implantational Loss conditions: Surgical Wound conditions: Healing Surgical Wounds conditions: Thin-gingiva studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: A randomized controlled equivalence clinical trial will be performed, with two parallel groups, a 1:1 allocation ratio, and a 12-month follow-up. primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 48 type: ESTIMATED name: Strip graft with Mucograft name: Free gingival graft measure: Changes in peri-implant keratinized mucosa width (mm) measure: Vascularization (in Laser Speckle perfusion units [LSPU]) measure: Changes in soft tissue thickness (STT) (mm) measure: Vestibule depth (VD) (mm) measure: Probing pocket depth (PPD) (mm) measure: Dehiscence (mm) measure: Full-mouth plaque score (FMPS) measure: Volumetric changes measure: Patient reported outcome measures (PROMS) measure: Esthetic analysis measure: Intra-surgical parameters measure: Intra-surgical time measure: Demographic data measure: Anamnesis data measure: Smoking habit measure: Full-mouth bleeding score (FMBS) (%) sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Complutense University status: RECRUITING city: Madrid zip: 28040 country: Spain name: Mariano Sanz Alonso role: CONTACT phone: 913942021 email: marsan@ucm.es name: Andrea Dobos, DMD role: SUB_INVESTIGATOR name: David Palombo, DMD role: SUB_INVESTIGATOR lat: 40.4165 lon: -3.70256 hasResults: False
nctId: NCT06261255 id: ATT_CS briefTitle: Autotransplantation and Enamel Matrix Derivatives Case Series acronym: ATTCS overallStatus: COMPLETED date: 2020-06-01 date: 2023-09-01 date: 2023-12-01 date: 2024-02-15 date: 2024-02-15 name: Universidad Complutense de Madrid class: OTHER briefSummary: The goal of this prospective case series is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level.
Participants will be subjected to a digitally protocol of tooth autotransplantation.Only one group (test) is assessed. It will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus. conditions: Tooth Loss studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: This clinical investigation is a single-center, prospective case series study and is reported in compliance with the Preferred Reporting of Case Series in Surgery (PROCESS) guidelines. The study was conducted at the Department of Periodontology of the University Complutense of Madrid between March 2021 and September 2023. primaryPurpose: TREATMENT masking: NONE count: 14 type: ACTUAL name: ATT + EMD measure: Clinical attachment level (CAL) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Universidad Complutense de Madrid city: Madrid zip: 28003 country: Spain lat: 40.4165 lon: -3.70256 facility: Universidad Complutense Madrid city: Madrid country: Spain lat: 40.4165 lon: -3.70256 hasResults: False
nctId: NCT06261242 id: TWM-C-2201 briefTitle: Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures Treatment overallStatus: RECRUITING date: 2023-06-16 date: 2025-02-28 date: 2025-07-31 date: 2024-02-15 date: 2024-02-16 name: National Cheng-Kung University Hospital class: OTHER briefSummary: This study is to evaluate the safety and effectiveness of the Tripod-Fix with Tecres Mendec® Spine HV System to treat subjects with osteoporotic vertebral compression fractures. conditions: Osteoporotic Vertebral Compression Fractures studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 12 type: ESTIMATED name: Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix) measure: Proportion of participants with study success sex: ALL minimumAge: 50 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National Cheng Kung University Hospital Department of Orthopedics status: RECRUITING city: Tainan zip: 704 country: Taiwan name: Susan Guo role: CONTACT phone: +8666-2353535 phoneExt: 3690 name: Cheng-Li Lin role: PRINCIPAL_INVESTIGATOR lat: 22.99083 lon: 120.21333 hasResults: False
nctId: NCT06261229 id: MURA2022/230 briefTitle: The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients overallStatus: ENROLLING_BY_INVITATION date: 2022-04-18 date: 2024-06-30 date: 2024-06-30 date: 2024-02-15 date: 2024-04-05 name: Mahidol University class: OTHER name: Health Systems Research Institute briefSummary: This study is a parallel randomized controlled trial (RCT). To determine the effect of intermittent fasting, intermittent fasting with behavioral economics, and intensive lifestyle modification on nutritional status; the differences between HOMA-IR, body weight change, and body composition in obese people.
The total sample size will be 123 participants. Blood and urine samples will be collected at baseline and each follow-up visit including 1-month, 2-months, 6-month, and 12-months, respectively for further study to find out the mechanisms of weight loss, weight regain, and the improvement in the metabolic disease. conditions: Intermittent Fasting conditions: Weight Loss conditions: Behavioral Economic conditions: Obese conditions: HOMA-IR studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 123 type: ESTIMATED name: Intermittent fasting name: Intermittent fasting + Behavioral economic name: Intensive Lifestyle Modification measure: HOMR-IR (index) measure: Body mass index (kg/m^2) measure: FBS (mg/dl) measure: HbA1C (%) measure: Albumin (g/L) measure: Creatinine (mg/dL) measure: Alanine transaminase (ALT) U/L measure: Aspartate transaminase (AST) U/L measure: Uric acid (mg/dL) measure: Total cholesterol (mg/dL) measure: HDL-C (mg/dL) measure: LDL-C (mg/dL) measure: Triglycerides (mg/dL) measure: Blood Urea Nitrogen (BUN) (mg/dL) measure: Urine albumin-creatinine ratio (UACR) (mg/g) measure: Energy from food (kilocalories) sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Mahidol University city: Ratchathewi state: Bangkok zip: 10400 country: Thailand lat: 13.759 lon: 100.53358 hasResults: False
nctId: NCT06261216 id: 01/2023/LPA-wtATTR/NVNS briefTitle: Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy overallStatus: RECRUITING date: 2024-02 date: 2025-02 date: 2025-02 date: 2024-02-15 date: 2024-02-15 name: Medical University of Graz class: OTHER name: Medical University Innsbruck briefSummary: The aim of this study is to investigate the association between increased lifetime physical activity and the development of wild-type transthyretin amyloid cardiomyopathy. conditions: Amyloid Cardiomyopathy conditions: Wild Type ATTR Amyloidosis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 252 type: ESTIMATED name: Interview measure: Association between lifetime physical activity and disease development measure: Association between lifetime athletic activity and disease development sex: ALL minimumAge: 60 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Medical University of Graz status: RECRUITING city: Graz country: Austria name: PI role: CONTACT phone: 0043 316 385 30173 email: nicolas.verheyen@medunigraz.at name: Nicolas Verheyen, MD PhD role: PRINCIPAL_INVESTIGATOR name: Nora Schwegel, MD role: SUB_INVESTIGATOR lat: 47.06667 lon: 15.45 hasResults: False
nctId: NCT06261203 id: Hany Hosny briefTitle: Low Dose Aspirin for Prevention of Early Pregnancy Loss overallStatus: RECRUITING date: 2023-07-01 date: 2025-07-01 date: 2025-07-15 date: 2024-02-15 date: 2024-02-15 name: Egymedicalpedia class: INDUSTRY briefSummary: Preeclampsia is a pregnancy-specific, multisystem disorder affecting 3% to 8% of pregnancies and remains a significant cause of maternal and neonatal morbidity and mortality worldwide.
The World Health Organization estimates that approximately 76,000 maternal deaths annually are attributed to preeclampsia, accounting for 16% of global maternal mortality, with the majority occurring in low- and middle-income countries conditions: Pre-Eclampsia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The The study's findings have the potential to clarify aspirin's role in preventing adverse pregnancy outcomes related to placental dysfunction and improve the management of women at risk of placental-mediated complications. primaryPurpose: PREVENTION masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 250 type: ESTIMATED name: Aspirin measure: Prevention of pregnancy loss sex: FEMALE minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: Assuit University hospitals status: RECRUITING city: Asyūţ state: Assuit country: Egypt name: Mohamed Nagy, Lecturer role: CONTACT phone: 01096655458 email: drmnagy@aun.edu.eg name: Abdelrahman Mahmoud, Assist.Prof. role: PRINCIPAL_INVESTIGATOR lat: 27.18096 lon: 31.18368 hasResults: False
nctId: NCT06261190 id: H-2308-182-1463 briefTitle: Active Surveillance for Low-risk Papillary Thyroid Carcinoma acronym: MAeSTroⅡ overallStatus: NOT_YET_RECRUITING date: 2024-03-04 date: 2029-12-31 date: 2032-12-31 date: 2024-02-15 date: 2024-02-26 name: National Cancer Center, Korea class: OTHER_GOV name: Seoul National University Bundang Hospital name: SMG-SNU Boramae Medical Center name: Seoul National University Hospital briefSummary: This study is an observational cohort study targeting patients with low-risk Papillary thyroid cancer who opted for active surveillance or immediate surgery based on a sufficient understanding of the treatment options. The primary objective of the study is to evaluate progression free survival of the patients with low-risk Papillary thyroid cancer who choose active surveillance, in other words, to observe the natural course of low-risk Papillary thyroid cancer. conditions: Thyroid Cancer conditions: Papillary Thyroid Carcinoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 499 type: ESTIMATED measure: Progression free survival of the patients with low-risk Papillary Thyroid Cancer who choose Active Surveillance measure: Disease progression measure: Rate of Participants in the Active Surveillance Group that change to surgery without disease progression measure: Comparison of Quality of Life between the Active Surveillance group and immediate surgery group measure: Measure of Anxiety and Depression measure: Measure of Satisfaction with the treatment measure: Factors influencing patients' decisions regarding disease management sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National Cancer Center city: Goyang-si country: Korea, Republic of name: Eun Kyung Lee role: PRINCIPAL_INVESTIGATOR lat: 37.65639 lon: 126.835 facility: Seoul National University Bundang Hospital city: Seongnam country: Korea, Republic of name: Jae Hoon Moon role: PRINCIPAL_INVESTIGATOR lat: 37.43861 lon: 127.13778 facility: Seoul National University Hospital city: Seoul country: Korea, Republic of name: Young Joo Park role: PRINCIPAL_INVESTIGATOR lat: 37.566 lon: 126.9784 facility: SMC-SNU Boramae Medical Center city: Seoul country: Korea, Republic of name: Ka Hi Lee role: PRINCIPAL_INVESTIGATOR lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06261177 id: 22-175 briefTitle: Take-home Functional Electrical Stimulation for MDD overallStatus: ACTIVE_NOT_RECRUITING date: 2023-12-04 date: 2024-12 date: 2025-03 date: 2024-02-15 date: 2024-02-15 name: Unity Health Toronto class: OTHER briefSummary: The purpose of this study is to learn whether Functional Electrical Stimulation (FES) of the facial muscles is effective in treating major depressive disorder (MDD) and to develop a model for take-home delivery. conditions: MDD studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE maskingDescription: Double-blind whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 20 type: ACTUAL name: Functional Electrical Stimulation (FES) name: Sham FES measure: Feasibility of the FES for MDD measure: Tolerability and safety of the FES for MDD measure: Improvement in symptoms of depression-17-item Hamilton Depression Rating Scale (HAM-D-17) measure: Improvement in symptoms of depression-16-Item Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR-16) measure: Improvement in symptoms of anxiety- General Anxiety Disorder (GAD-7) measure: Improvement in well-being-World Health Organization-5 Well-Being Index (WHO-5) measure: Improvement in sleep quality- Pittsburgh Sleep Quality Index (PSQI) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: St. Michael's Hospital city: Toronto state: Ontario country: Canada lat: 43.70011 lon: -79.4163 hasResults: False
nctId: NCT06261164 id: 01-19-373- 2/23 briefTitle: Population Pharmacokinetic Model of Amikacin and Vancomycin in Critically Ill Patients overallStatus: RECRUITING date: 2024-01-31 date: 2024-12-31 date: 2025-01-31 date: 2024-02-15 date: 2024-02-15 name: University Clinical Centre of Republic of Srpska class: OTHER briefSummary: The object of the scientific research is the characterization of the pharmacokinetic profile and the investigation of factors of pharmacokinetic variability of amikacin and vacnomycin in critically ill patients with a diagnosis of sepsis-like condition (SIRS), hospital-acquired sepsis and/or septic shock and who are on extracorporeal therapy with Cytosorb® and Oxiris® adsorbents. conditions: Sepsis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 20 type: ESTIMATED name: Cytosorb® and Oxiris® adsorbents measure: Development of population pharmacokinetic model sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Department of Medical Intensive Care Medicine status: RECRUITING city: Banja Luka zip: 78000 country: Bosnia and Herzegovina name: Nikolina Spiric, MPharm role: CONTACT phone: +38751342295 email: nikolina.spiric@kc-bl.com name: Pedja Kovacevic, Prof. role: SUB_INVESTIGATOR lat: 44.77842 lon: 17.19386 hasResults: False
nctId: NCT06261151 id: Zhongshan-HHY-03 briefTitle: Preoperative Nutritional Status Associated With Delayed Discharge in Elderly Patients Undergoing Gastrectomy overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-12-31 date: 2025-03-31 date: 2024-02-15 date: 2024-02-15 name: Shanghai Zhongshan Hospital class: OTHER briefSummary: Gastric cancer (GC) remains the 5th most common cancer worldwide and had the second- highest mortality rate in China. The population of elder patients with GC has been increasing because of the high prevalence of H. pylori infection and increasing life expectancy. Elderly GC patients face several challenges during treatment, such as comorbidities, organ dysfunction, immunosuppression, and delayed recovery. Advanced age is associated with a higher rate of postoperative complications shortly after surgical treatment, and lower 5-year overall survival as long-term outcome.
In China, the prevalence of malnutrition in hospitalized patients is around 12.6% to 46.19%. Malnutrition is one of the great risk factors of adverse clinical outcomes in elderly patients with GC. The nutritional status at the time of diagnosis was independently associated with postoperative complications, overall survival, and disease-free survival. The condition can be caused by mechanical obstruction of the digestive tract or anorexia-cachexia syndrome, leading to insufficient protein or energy intake and absorption disorder. Nutrition screening, assessment, and intervention are important steps in nutritional management.
Previous studies mostly focused on hospitalized internal medical patients. Only a few studies focused on surgical patients regardless of age. Therefore, in this retrospective study, we are going to investigate the nutritional status and perioperative nutritional support of geriatric surgical patients with GC, and provide a basis for implementing an effective nutritional intervention. conditions: Preoperative Nutritional Status and Risk Factors Associated With Elderly Patients Undergoing Gastrectomy studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 1000 type: ESTIMATED name: Clinical data collection measure: The preoperative nutritional status of elderly patients underwent gastrectomy sex: ALL minimumAge: 60 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06261138 id: RSR-HCC-2019-001 briefTitle: Survival Analysis: TACE vs. Combination Therapy in HCC overallStatus: COMPLETED date: 2019-02-01 date: 2023-03-31 date: 2023-10-31 date: 2024-02-15 date: 2024-02-15 name: Zhejiang University class: OTHER briefSummary: This retrospective observational study aimed to assess potential improvements associated with systemic therapies in patients receiving transarterial chemoembolization (TACE) for initially unresectable HCC. conditions: Hepatocellular Carcinoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 279 type: ACTUAL name: Transarterial chemoembolization name: Systemic treatment measure: Progression Free Survival (PFS) per mRECIST measure: 12 months PFS rate measure: Overall survival (OS) measure: Objective Response Rate (ORR) per mRECIST measure: Disease Control Rate (DCR) per mRECIST measure: Adverse events (AEs) sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: First Affiliated Hospital, Medical College of Zhejiang University city: Hangzhou state: Zhejiang zip: 310003 country: China lat: 30.29365 lon: 120.16142 hasResults: False
nctId: NCT06261125 id: SL-B2023-718 briefTitle: Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401) acronym: HSBRT2401 overallStatus: RECRUITING date: 2024-03-10 date: 2026-06-30 date: 2028-06-30 date: 2024-02-15 date: 2024-03-12 name: Mian XI class: OTHER briefSummary: Abdominal lymph node metastasis (LNM) is one of the major modes of extrahepatic metastasis in hepatocellular carcinoma (HCC). Immunotherapy targeting the PD-1/PD-L1 checkpoints combined with targeted therapy is the standard treatment for HCC with abdominal LNM, but the outcome remains very poor, with an objective response rate of 5% to 30%. Previous studies have demonstrated that stereotactic body radiotherapy (SBRT) is an effective local treatment for HCC with abdominal LNM, with a high response rate of 60% to 80%. However, intrahepatic dissemination and distant metastasis remains the major recurrence pattern after SBRT in these patients, suggesting radiotherapy should be combined with systematic treatment. Recently, the combination of immunotherapy with SBRT has shown promising activity in HCC. The aim of this study was to investigate the efficacy and safety of SBRT followed by adebrelimab (an anti-PD-L1 antibody) and lenvatinib in HCC patients with portal abdominal LNM. conditions: Hepatocellular Carcinoma studyType: INTERVENTIONAL phases: PHASE2 allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 60 type: ESTIMATED name: Stereotactic body radiotherapy name: Adebrelimab name: Lenvatinib measure: Progression-free survival (PFS) measure: Overall survival (OS) measure: Overall response rate (ORR) measure: Disease control rate (DCR) measure: Duration of response (DOR) measure: Treatment-related adverse events measure: Correlation between serum cytokines and overall survival and immune-related adverse events sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Mian Xi status: RECRUITING city: Guangzhou state: Guangdong zip: 510060 country: China name: Mian Xi, MD role: CONTACT phone: +862087343385 email: ximian@sysucc.org.cn name: Mian Xi, MD role: PRINCIPAL_INVESTIGATOR lat: 23.11667 lon: 113.25 hasResults: False